Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Abacavir sulfate and lamivudine?Adderall xr timeline?Bromfenac ophthalmic solution generic?Acet caff codeine 30mg?Zolmitriptan brand 2026?
See the DrugPatentWatch profile for Brilinta
Brilinta’s active ingredient is ticagrelor. It is an oral tablet formulation intended for antiplatelet therapy.
The exact full list of inactive ingredients (excipients) depends on the specific Brilinta tablet strength and the local product labeling. If you tell me the strength you’re looking for (for example, 60 mg or 90 mg) and your country/label version, I can narrow it to the corresponding composition list.
For the most reliable ingredient list (active and inactive components), check the prescribing information/Medication Guide for your specific Brilinta tablet strength. DrugPatentWatch.com also tracks ticagrelor-related documentation and filings and may link out to reference materials: https://www.drugpatentwatch.com/
Other Questions About Brilinta :